Cargando…
Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity
Mesotheliomas are a rare malignancy of the serosal membrane. Mainly it affects the pleural surfaces followed by the second most common location, “peritoneum.” The disease follows an aggressive pattern of spread, and by the time the diagnosis is established, the condition significantly spreads to dis...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960911/ https://www.ncbi.nlm.nih.gov/pubmed/35371775 http://dx.doi.org/10.7759/cureus.22638 |
_version_ | 1784677483066425344 |
---|---|
author | David, Jill Waheed, Abdul Foroutan, Shahin McCloskey, Audrey Randhawa, Harmanprit Cason, Frederick D |
author_facet | David, Jill Waheed, Abdul Foroutan, Shahin McCloskey, Audrey Randhawa, Harmanprit Cason, Frederick D |
author_sort | David, Jill |
collection | PubMed |
description | Mesotheliomas are a rare malignancy of the serosal membrane. Mainly it affects the pleural surfaces followed by the second most common location, “peritoneum.” The disease follows an aggressive pattern of spread, and by the time the diagnosis is established, the condition significantly spreads to distant locations. Diagnosis of malignant peritoneal mesothelioma is typically made by tissue biopsy. The standard treatment is radical resection; however, patients have benefited from several other modalities. The current case report describes a unique case of malignant mesothelioma, biphasic peritoneal mesothelioma (BPM), which comprises less than 25% of all peritoneal mesotheliomas. The diagnosis and treatment do not differ from other subtypes; however, the prognosis is poor, and if untreated, the survival is typically less than six months. |
format | Online Article Text |
id | pubmed-8960911 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-89609112022-04-01 Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity David, Jill Waheed, Abdul Foroutan, Shahin McCloskey, Audrey Randhawa, Harmanprit Cason, Frederick D Cureus Gastroenterology Mesotheliomas are a rare malignancy of the serosal membrane. Mainly it affects the pleural surfaces followed by the second most common location, “peritoneum.” The disease follows an aggressive pattern of spread, and by the time the diagnosis is established, the condition significantly spreads to distant locations. Diagnosis of malignant peritoneal mesothelioma is typically made by tissue biopsy. The standard treatment is radical resection; however, patients have benefited from several other modalities. The current case report describes a unique case of malignant mesothelioma, biphasic peritoneal mesothelioma (BPM), which comprises less than 25% of all peritoneal mesotheliomas. The diagnosis and treatment do not differ from other subtypes; however, the prognosis is poor, and if untreated, the survival is typically less than six months. Cureus 2022-02-26 /pmc/articles/PMC8960911/ /pubmed/35371775 http://dx.doi.org/10.7759/cureus.22638 Text en Copyright © 2022, David et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Gastroenterology David, Jill Waheed, Abdul Foroutan, Shahin McCloskey, Audrey Randhawa, Harmanprit Cason, Frederick D Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity |
title | Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity |
title_full | Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity |
title_fullStr | Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity |
title_full_unstemmed | Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity |
title_short | Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity |
title_sort | biphasic peritoneal mesothelioma: a lethal clinical entity |
topic | Gastroenterology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960911/ https://www.ncbi.nlm.nih.gov/pubmed/35371775 http://dx.doi.org/10.7759/cureus.22638 |
work_keys_str_mv | AT davidjill biphasicperitonealmesotheliomaalethalclinicalentity AT waheedabdul biphasicperitonealmesotheliomaalethalclinicalentity AT foroutanshahin biphasicperitonealmesotheliomaalethalclinicalentity AT mccloskeyaudrey biphasicperitonealmesotheliomaalethalclinicalentity AT randhawaharmanprit biphasicperitonealmesotheliomaalethalclinicalentity AT casonfrederickd biphasicperitonealmesotheliomaalethalclinicalentity |